ArticleAlzheimer's research & therapy2026
Combining OCT and OCT angiography improves differentiation of mild cognitive impairment and Alzheimer's disease.
Article in Alzheimer's research & therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- A multi-omics and machine-learning framework reveals shared druggable targets for Alzheimer's disease and periodontitis and identifies amentoflavone and taraxerone as potential dual-action natural products.Naunyn-Schmiedeberg's archives of pharmacology · 2026Article
- Multimodal Retinal Imaging for the Detection of Early Alzheimer's Disease: Combining Biochemical, Structural, and Vascular Biomarkers.Bioengineering (Basel, Switzerland) · 2026Article
- Retinal Microvascular Biomarkers Measured by Optical Coherence Tomography Angiography in Neurodegenerative and Neurovascular Disorders: A Systematic Review and Meta-Analysis.Clinical ophthalmology (Auckland, N.Z.) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
backgroundTo evaluate retinal structural and vascular differences in probable Alzheimer's disease (AD) and mild cognitive impairment (MCI) using optical coherence tomography (OCT) and OCT angiography (OCTA), and to assess their combined performance in differentiating MCI/probable AD individuals with no cognitive impairment (NCI).
methodsA cross-sectional study of 196 participants (NCI = 60; MCI = 83; probable AD = 53) recruited from two memory clinics, with good-quality OCT and OCTA scans, was conducted. Retinal layer thickness and vessel density were calculated using OCT/OCTA. Generalized estimating equations were used to compare groups, adjusting for relevant covariates. Receiver operating characteristic (ROC) curves assessed diagnostic accuracy.
resultsParticipants with MCI/probable AD were older (77 ± 6 years vs. 73 ± 9 years, p = 0.004) compared with controls, but sex distribution was similar (40% vs. 42% male, p = 0.796). The inner nuclear layer (β = 1.70 μm, p = 0.028) and inner segment/outer segment (IS/OS) layers (β = 0.51 μm, p = 0.003) were significantly thicker, while the outer nuclear layer was significantly thinner (β=-5.80 μm, p = 0.049) in MCI/probable AD participants compared to normal controls. OCTA showed reduced vessel densities in the superficial (β=-0.69%, p = 0.018) and deep capillary plexuses (β=-2.23%, p = 0.010), along with a larger deep foveal avascular zone perimeter (β = 0.18 μm, p = 0.038) in MCI/AD. Diagnostic performance was moderate for individual OCT (0.52-0.64) and OCTA layers (0.56-0.66). Combining OCT and OCTA significantly improved diagnostic accuracy (AUC = 0.90, p < 0.001), with a sensitivity of 81%, specificity of 87%, and highest Youden Index (0.67), compared to OCTA (0.55) and OCT (0.47).
conclusionsIntegrating OCT- and OCTA-derived metrics significantly improved discriminative performance compared with either modality alone, underscoring their complementary value in capturing distinct structural and vascular alterations associated with cognitive impairment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.